{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:16:33Z","timestamp":1775081793369,"version":"3.50.1"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31730054"],"award-info":[{"award-number":["31730054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31770900"],"award-info":[{"award-number":["31770900"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["5212016"],"award-info":[{"award-number":["5212016"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","award":["2018YFA0507101"],"award-info":[{"award-number":["2018YFA0507101"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","award":["2021YFA1300301"],"award-info":[{"award-number":["2021YFA1300301"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijbiomac.2026.150223","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:41:24Z","timestamp":1768376484000},"page":"150223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["RNAi therapy targeting coronavirus genomes, pulmonary delivery strategies and design principles: A review"],"prefix":"10.1016","volume":"341","author":[{"given":"Hao","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiwei","family":"Huangyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6669","key":"10.1016\/j.ijbiomac.2026.150223_bb0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150223_bb0010","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin lowering strategies for disease modification in Huntington\u2019s disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114113","article-title":"RNAi-based therapeutics and tumor targeted delivery in cancer","volume":"182","author":"Kara","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.addr.2016.03.005","article-title":"Recent advances in RNAi-based strategies for therapy and prevention of HIV-1\/AIDS","volume":"103","author":"Swamy","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150223_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/v12080851","article-title":"Advances with RNAi-based therapy for hepatitis B virus infection","volume":"12","author":"van den Berg","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150223_bb0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/14712598.5.4.495","article-title":"Polycation-mediated delivery of siRNAs for prophylaxis and treatment of influenza virus infection","volume":"5","author":"Thomas","year":"2005","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150223_bb0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/path.1440","article-title":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","volume":"200","author":"Ding","year":"2003","journal-title":"J. Pathol."},{"issue":"40","key":"10.1016\/j.ijbiomac.2026.150223_bb0040","first-page":"820","article-title":"Severe respiratory illness associated with a novel coronavirus\u2014Saudi Arabia and Qatar, 2012","volume":"61","year":"2012","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01315534","article-title":"Antigenic relationship of the feline infectious peritonitis virus to coronaviruses of other species","volume":"58","author":"Pedersen","year":"1978","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0050","article-title":"Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate","volume":"368","author":"Mahase","year":"2020","journal-title":"Bmj"},{"issue":"5\u20136","key":"10.1016\/j.ijbiomac.2026.150223_bb0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000507423","article-title":"COVID-19 outbreak: an overview","volume":"64","author":"Ciotti","year":"2019","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150223_bb0060","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ame2.12336","article-title":"The protection of CoronaVac against the infection of wild-type SARS-CoV-2 (WH-09) or Omicron variant in nude-hACE2 mice","volume":"6","author":"Lin","year":"2023","journal-title":"Anim. Model Exp. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ymthe.2023.11.019","article-title":"A cardiotoxicity-eliminated ACE2 variant as a pan-inhibitor against coronavirus cell invasion","volume":"32","author":"Feng","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.616993","article-title":"The potential therapeutic effect of RNA interference and natural products on COVID-19: a review of the coronaviruses infection","volume":"12","author":"Kalhori","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105246","article-title":"Human coronaviruses: origin, host and receptor","volume":"155","author":"Tang","year":"2022","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150223_bb0080","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001840","article-title":"Virus taxonomy and the role of the International Committee on Taxonomy of Viruses (ICTV)","volume":"104","author":"Siddell","year":"2023","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150223_bb0085","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001843","article-title":"ICTV virus taxonomy profile: Coronaviridae 2023","volume":"104","author":"Woo","year":"2023","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3181\/00379727-121-30734","article-title":"A new virus isolated from the human respiratory tract","volume":"121","author":"Hamre","year":"1966","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150223_bb0095","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/oxfordjournals.aje.a121171","article-title":"Seroepidemiologic studies of coronavirus infection in adults and children","volume":"91","author":"McIntosh","year":"1970","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150223_bb0100","first-page":"234","article-title":"Medical reviews. Coronaviruses","volume":"47","author":"Monto","year":"1974","journal-title":"Yale J. Biol. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.150223_bb0105","article-title":"Feline coronavirus and alpha-herpesvirus infections: innate immune response and immune escape mechanisms","volume":"11","author":"Capozza","year":"2021","journal-title":"Animals (Basel)."},{"issue":"7798","key":"10.1016\/j.ijbiomac.2026.150223_bb0110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses","volume":"66","author":"Masters","year":"2006","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0120","series-title":"StatPearls","article-title":"Features, evaluation, and treatment of coronavirus (COVID-19)","author":"Cascella","year":"2024"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0125","article-title":"Human SARS-CoV-2 has evolved to reduce CG dinucleotide in its open reading frames","volume":"10","author":"Wang","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150223_bb0130","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1093\/nar\/gkae144","article-title":"Conserved structures and dynamics in 5\u2032-proximal regions of Betacoronavirus RNA genomes","volume":"52","author":"de Moura","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105677","article-title":"Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2","volume":"217","author":"Bowden-Reid","year":"2023","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150223_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/acg2.107","article-title":"An in silico analysis of effective siRNAs against COVID-19 by targeting the leader sequence of SARS-CoV-2","volume":"4","author":"Pandey","year":"2021","journal-title":"Adv. Cell Gene Ther."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2217\/fmb-2021-0130","article-title":"Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest","volume":"17","author":"Saba","year":"2022","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0150","article-title":"RNAi-mediated siRNA sequences to combat the COVID-19 pandemic with the inhibition of SARS-CoV2","volume":"26","author":"Saadat","year":"2022","journal-title":"Gene Rep."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105815","article-title":"An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity","volume":"222","author":"Idris","year":"2024","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150223_bb0160","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jmii.2023.02.010","article-title":"Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection","volume":"56","author":"Supramaniam","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.150223_bb0165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219523120","article-title":"Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection","volume":"120","author":"Hariharan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150223_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.102049","article-title":"In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells","volume":"34","author":"Sartaj Sohrab","year":"2022","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.801870","article-title":"Selection and validation of siRNAs preventing uptake and replication of SARS-CoV-2","volume":"10","author":"Friedrich","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150223_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.101965","article-title":"Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells","volume":"34","author":"Sohrab","year":"2022","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jconrel.2022.03.051","article-title":"Inhibition of SARS-CoV-2 replication in the lung with siRNA\/VIPER polyplexes","volume":"345","author":"Baldassi","year":"2022","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150223_bb0190","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115298","article-title":"A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant","volume":"14","author":"Chang","year":"2022","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/nar\/gkab1248","article-title":"Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread","volume":"50","author":"Ambike","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.150223_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/v13102030","article-title":"Inhibition of SARS-CoV-2 replication by a small interfering RNA targeting the leader sequence","volume":"13","author":"Tolksdorf","year":"2021","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150223_bb0205","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.ymthe.2021.05.004","article-title":"A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19","volume":"29","author":"Idris","year":"2021","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150223_bb0210","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.7150\/ijbs.59151","article-title":"Developing effective siRNAs to reduce the expression of key viral genes of COVID-19","volume":"17","author":"Wu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0215","article-title":"Computational design and experimental evaluation of MERS-CoV siRNAs in selected cell lines","volume":"13","author":"Sohrab","year":"2023","journal-title":"Diagnostics (Basel)."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150223_bb0220","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jiph.2020.12.018","article-title":"Designing and evaluation of MERS-CoV siRNAs in HEK-293 cell line","volume":"14","author":"Sohrab","year":"2021","journal-title":"J. Infect. Public Health"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150223_bb0225","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.sjbs.2020.11.066","article-title":"In silico prediction and experimental validation of siRNAs targeting ORF1ab of MERS-CoV in Vero cell line","volume":"28","author":"Sohrab","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"issue":"3 Suppl 4","key":"10.1016\/j.ijbiomac.2026.150223_bb0230","first-page":"28","article-title":"Development of interfering RNA agents to inhibit SARS-associated coronavirus infection and replication","volume":"15","author":"He","year":"2009","journal-title":"Hong Kong Med. J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150223_bb0235","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.antiviral.2006.10.008","article-title":"Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a\/7b, 3a\/3b and S","volume":"73","author":"Akerstr\u00f6m","year":"2007","journal-title":"Antivir. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150223_bb0240","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1280","article-title":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque","volume":"11","author":"Li","year":"2005","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150223_bb0245","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.gt.3302479","article-title":"siRNA targeting the leader sequence of SARS-CoV inhibits virus replication","volume":"12","author":"Li","year":"2005","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2004.09.005","article-title":"Inhibition of SARS-CoV replication by siRNA","volume":"65","author":"Wu","year":"2005","journal-title":"Antivir. Res."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.150223_bb0255","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1128\/JVI.78.14.7523-7527.2004","article-title":"Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells","volume":"78","author":"Wang","year":"2004","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.150223_bb0260","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.3390\/molecules15107197","article-title":"Small interfering RNA effectively inhibits the expression of SARS coronavirus membrane gene at two novel targeting sites","volume":"15","author":"Wang","year":"2010","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150223_bb0265","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jviromet.2007.05.017","article-title":"siRNAs targeting terminal sequences of the SARS-associated coronavirus membrane gene inhibit M protein expression through degradation of M mRNA","volume":"145","author":"Qin","year":"2007","journal-title":"J. Virol. Methods"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150223_bb0270","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.cr.7290286","article-title":"Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs","volume":"15","author":"Shi","year":"2005","journal-title":"Cell Res."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.150223_bb0275","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vetmic.2014.12.009","article-title":"Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro","volume":"176","author":"McDonagh","year":"2015","journal-title":"Vet. Microbiol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150223_bb0280","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2460\/ajvr.75.9.828","article-title":"Effect of small interfering RNAs on in vitro replication and gene expression of feline coronavirus","volume":"75","author":"Anis","year":"2014","journal-title":"Am. J. Vet. Res."},{"issue":"3\u20134","key":"10.1016\/j.ijbiomac.2026.150223_bb0285","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.vetmic.2011.01.023","article-title":"In vitro inhibition of feline coronavirus replication by small interfering RNAs","volume":"150","author":"McDonagh","year":"2011","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0290","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.csbj.2025.03.034","article-title":"In silico and in vitro development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2","volume":"27","author":"Taibe","year":"2025","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150223_bb0295","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ame2.12278","article-title":"Characteristics of animal models for COVID-19","volume":"5","author":"Qi","year":"2022","journal-title":"Anim. Model Exp. Med."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0300","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejmech.2016.03.080","article-title":"A combined approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems","volume":"117","author":"Carta","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0305","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.sjbs.2021.09.002","article-title":"Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of an approach","volume":"29","author":"Mir","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150223_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083456","article-title":"Recent update on siRNA therapeutics","volume":"26","author":"Ebenezer","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150223_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21091249","article-title":"Delivery of RNAi therapeutics to the airways - from bench to bedside","volume":"21","author":"Qiu","year":"2016","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150223_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/nano7040077","article-title":"siRNA delivery strategies: a comprehensive review of recent developments","volume":"7","author":"Tatiparti","year":"2017","journal-title":"Nanomaterials (Basel)."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150223_bb0325","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4155\/tde-2019-0009","article-title":"Pulmonary delivery of siRNA as a novel treatment for lung diseases","volume":"10","author":"Kandil","year":"2019","journal-title":"Ther. Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0330","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41467-024-53914-x","article-title":"Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150223_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052408","article-title":"Nanoparticle delivery platforms for RNAi therapeutics targeting COVID-19 disease in the respiratory tract","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0340","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12951-023-02147-z","article-title":"Engineering siRNA therapeutics: challenges and strategies","volume":"21","author":"Ali Zaidi","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56455-2","article-title":"Effective lung-targeted RNAi in mice with peptide-based delivery of nucleic acid","volume":"9","author":"Kurrikoff","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150223_bb0350","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41563-023-01472-w","article-title":"Hydrogels for RNA delivery","volume":"22","author":"Zhong","year":"2023","journal-title":"Nat. Mater."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150223_bb0355","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.apsb.2021.08.009","article-title":"Pulmonary delivery of siRNA against acute lung injury\/acute respiratory distress syndrome","volume":"12","author":"Zoulikha","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150223_bb0360","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314747121","article-title":"Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery","volume":"121","author":"Zhao","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2026.150223_bb0365","article-title":"Nano-scale delivery systems for siRNA delivery in cancer therapy: new era of gene therapy empowered by nanotechnology","volume":"239","author":"Ebrahimi","year":"2023","journal-title":"Environ. Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.150223_bb0370","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1007\/s13346-025-01815-x","article-title":"Preclinical testing of antiviral siRNA therapeutics delivered in lipid nanoparticles in animal models-a comprehensive review","volume":"15","author":"Idres","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0375","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2014.05.018","article-title":"siRNA delivery to the lung: what\u2019s new?","volume":"75","author":"Merkel","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150223_bb0380","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.nano.2017.08.001","article-title":"Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammation","volume":"13","author":"Frede","year":"2017","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0385","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12951-024-02414-7","article-title":"Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases","volume":"22","author":"Jiang","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.150223_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304525","article-title":"Exploring mechanisms of lipid nanoparticle-mucus interactions in healthy and cystic fibrosis conditions","volume":"13","author":"Tafech","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.150223_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12111042","article-title":"Aerosolizable lipid nanoparticles for pulmonary delivery of mRNA through design of experiments","volume":"12","author":"Zhang","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150223_bb0400","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1039\/D1NR06512B","article-title":"Pulmonary delivery of mucosal nanovaccines","volume":"14","author":"Tang","year":"2022","journal-title":"Nanoscale"},{"issue":"26","key":"10.1016\/j.ijbiomac.2026.150223_bb0405","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312026","article-title":"Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions","volume":"36","author":"Omo-Lamai","year":"2024","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.150223_bb0410","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307801120","article-title":"Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart","volume":"121","author":"Radmand","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"42","key":"10.1016\/j.ijbiomac.2026.150223_bb0415","article-title":"Lung-targeted lipid nanoparticle-delivered siUSP33 attenuates SARS-CoV-2 replication and virulence by promoting envelope degradation","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0420","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12951-024-03064-5","article-title":"Lipid-encapsulated gold nanoparticles: an advanced strategy for attenuating the inflammatory response in SARS-CoV-2 infection","volume":"23","author":"Dhandapani","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0425","article-title":"Optimizing the intracellular delivery of therapeutic anti-inflammatory TNF-\u03b1 siRNA to activated macrophages using lipidoid-polymer hybrid nanoparticles","volume":"8","author":"Lokras","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0430","first-page":"1","article-title":"Fluorinated amphiphilic poly(\u03b2-amino ester) nanoparticle for highly efficient and specific delivery of nucleic acids to the lung capillary endothelium","volume":"31","author":"Deng","year":"2024","journal-title":"Bioact. Mater."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150223_bb0435","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1165\/rcmb.2020-0306TR","article-title":"Nanoparticle delivery systems with cell-specific targeting for pulmonary diseases","volume":"64","author":"Deng","year":"2021","journal-title":"Am. J. Resp. Cell. Mol."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2019.01.002","article-title":"Polymeric nanoparticles for the delivery of miRNA to treat chronic obstructive pulmonary disease (COPD)","volume":"136","author":"Mohamed","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115147","article-title":"Emerging delivery approaches for targeted pulmonary fibrosis treatment","volume":"204","author":"Diwan","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150223_bb0450","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.healun.2024.02.191","article-title":"AAV delivery of PD-L1 with concomitant CTLA-4 immunoglobulin attenuates acute cellular rejection in a rat lung transplant model","volume":"43","author":"Alderete","year":"2024","journal-title":"J. Heart Lung Transplant."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150223_bb0455","article-title":"Cross-species tropism of AAV.CPP.16 in the respiratory tract and its gene therapies against pulmonary fibrosis and viral infection","volume":"6","author":"Yang","year":"2025","journal-title":"Cell. Rep. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0460","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1038\/s41467-019-10562-w","article-title":"Regulating intracellular fate of siRNA by endoplasmic reticulum membrane-decorated hybrid nanoplexes","volume":"10","author":"Qiu","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0465","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1248\/cpb.c25-00576","article-title":"A compensated forster resonance energy transfer-based platform for quantitative assessment of liposome integrity in inhalation drug delivery","volume":"74","author":"Togami","year":"2026","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150223_bb0470","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41422-021-00491-z","article-title":"In vivo self-assembled small RNAs as a new generation of RNAi therapeutics","volume":"31","author":"Fu","year":"2021","journal-title":"Cell Res."},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.150223_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202308775","article-title":"Pulmonary siRNA delivery with sophisticated amphiphilic poly (Spermine Acrylamides) for the treatment of lung fibrosis","volume":"20","author":"Adams","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0480","doi-asserted-by":"crossref","first-page":"14219","DOI":"10.2147\/IJN.S545306","article-title":"Inhalable exosomes in respiratory therapies with the transformative potential","volume":"20","author":"Gou","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0485","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41392-025-02262-3","article-title":"Clinical investigation on nebulized human umbilical cord MSC-derived extracellular vesicles for pulmonary fibrosis treatment","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0490","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12951-024-02473-w","article-title":"Modulation of alveolar macrophage and mitochondrial fitness by medicinal plant-derived nanovesicles to mitigate acute lung injury and viral pneumonia","volume":"22","author":"Ye","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0495","article-title":"Self-assembled vectors derived from Aster tataricus L.f. mitigate bleomycin-induced pulmonary fibrosis in mice","volume":"32","author":"Meng","year":"2025","journal-title":"Mater. Today Bio."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150223_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102227","article-title":"A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replication","volume":"35","author":"Tuttolomondo","year":"2024","journal-title":"Mol. Ther. Nucleic Acids."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150223_bb0505","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0510","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jconrel.2020.11.005","article-title":"Pulmonary siRNA delivery for lung disease: review of recent progress and challenges","volume":"330","author":"Ding","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.150223_bb0515","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.actbio.2025.07.068","article-title":"Inhalable nucleic acid therapeutics for chronic pulmonary disease: progress, challenges, and prospects","volume":"204","author":"Wang","year":"2025","journal-title":"Acta Biomater."},{"issue":"29","key":"10.1016\/j.ijbiomac.2026.150223_bb0520","doi-asserted-by":"crossref","first-page":"48222","DOI":"10.18632\/oncotarget.18421","article-title":"Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics","volume":"8","author":"Gentile","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150223_bb0525","article-title":"Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduct. Tar."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150223_bb0530","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.apsb.2022.11.019","article-title":"Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome","volume":"13","author":"Uddin","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150223_bb0535","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1111\/all.14850","article-title":"Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation","volume":"76","author":"Khaitov","year":"2021","journal-title":"Allergy"},{"issue":"23","key":"10.1016\/j.ijbiomac.2026.150223_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236088","article-title":"siRNA conjugated nanoparticles - a next generation strategy to treat lung cancer","volume":"20","author":"Itani","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026001492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026001492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:44:25Z","timestamp":1773978265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026001492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":108,"alternative-id":["S0141813026001492"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150223","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNAi therapy targeting coronavirus genomes, pulmonary delivery strategies and design principles: A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"150223"}}